The NVD has served as the global database of vulnerabilities for over 25 years.
Since 2023, tens of thousands of vulnerabilities have gone unanalyzed. Efforts by CISA and the private industry to close this gap have been unsuccessful, and the risk posed by high-severity vulnerabilities continues to grow.This webinar will explore the changes that led to this issue and examine examples of high-risk vulnerabilities that remain unanalyzed—potentially impacting healthcare systems. Hosted by Daniel Beard, Medcrypt Senior Software Engineer, this session will showcase approaches using LLMs to compensate for the lack of analysis. Daniel will demonstrate a unique solution for identifying these high-risk vulnerabilities.
Attendees will:
- Understand the impact of the NVD analysis gap on cybersecurity, particularly in healthcare
- Learn how LLMs can assist analysts in enriching, normalizing and filtering raw vulnerability data
- Explore LLM-based approaches to bridging the analysis gap, including a novel solution for identifying threats
Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!
.svg)